Regeneron PharmaceuticalsRegeneron Pharmaceuticals
RP

Regeneron Pharmaceuticals

A biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases.

1988Active

About

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company founded in 1988, headquartered in Westchester County, New York. The company focuses on discovering and developing innovative medicines for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. With 13 medicines approved and nearly 100% of products invented in-house, Regeneron serves patients in over 100 countries. The company invested $4.4 billion into R&D in 2023 with 30+ programs in clinical development.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$150/mo
CDN
Cloudflare
EmailProofpoint
gateway-fronted
Stack
Bootstrap
Analytics
Google Tag Manager
Video
Vimeo
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Regeneron Pharmaceuticals do?

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company founded in 1988, headquartered in Westchester County, New York. The company focuses on discovering and developing innovative medicines for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. With 13 medicines approved and nearly 100% of products invented in-house, Regeneron serves patients in ove…

Where is Regeneron Pharmaceuticals headquartered?

Regeneron Pharmaceuticals is headquartered in Westchester County, New York, United States.

When was Regeneron Pharmaceuticals founded?

Regeneron Pharmaceuticals was founded in 1988.

What industry does Regeneron Pharmaceuticals operate in?

Regeneron Pharmaceuticals operates in Biotech, Pharmaceuticals, MedTech, Drug Discovery, Clinical Trials, Therapeutics.